| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D FAM13B TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.45e-08 | 279 | 126 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D FAM13B TBC1D3C TBC1D3B TBC1D26 ABHD5 RPTOR TBC1D3I IL2 TBC1D3G TBC1D3K TBC1D3F | 3.83e-06 | 656 | 126 | 16 | GO:0008047 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYCBP2 FAM13B TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.96e-06 | 507 | 126 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYCBP2 FAM13B TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.96e-06 | 507 | 126 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E BIN1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYCBP2 CIP2A FAM13B TBC1D3C TBC1D3B TBC1D26 ABHD5 SPOCK3 RPTOR WFIKKN2 TBC1D3I IL2 TBC1D3G TBC1D3K TBC1D3F | 2.09e-04 | 1418 | 126 | 21 | GO:0030234 |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor binding | 2.35e-04 | 4 | 126 | 2 | GO:0001025 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.73e-12 | 109 | 125 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D26 PROM2 MTOR TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.64e-08 | 335 | 125 | 14 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.10e-08 | 244 | 125 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | RAG1 TBC1D3E BIN1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D RIPK2 TBC1D3C TBC1D3B TBC1D26 PROM2 CARD9 SPOCK3 MTOR WFIKKN2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.21e-07 | 878 | 125 | 20 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RIPK2 TBC1D3C TBC1D3B TBC1D26 CARD9 MTOR TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.65e-07 | 499 | 125 | 15 | GO:0051345 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D28 TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.47e-15 | 53 | 129 | 12 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D28 TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.39e-15 | 55 | 129 | 12 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D28 TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.39e-15 | 55 | 129 | 12 | PS50086 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D26 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.58e-14 | 49 | 129 | 11 | SM00164 |
| Domain | ARM-like | 1.09e-04 | 270 | 129 | 9 | IPR011989 | |
| Domain | ARM-type_fold | 1.24e-04 | 339 | 129 | 10 | IPR016024 | |
| Domain | - | 1.56e-04 | 222 | 129 | 8 | 1.25.10.10 | |
| Domain | AWS | 4.67e-04 | 5 | 129 | 2 | SM00570 | |
| Domain | AWS | 4.67e-04 | 5 | 129 | 2 | PS51215 | |
| Domain | AWS_dom | 4.67e-04 | 5 | 129 | 2 | IPR006560 | |
| Domain | ZP_dom_CS | 2.05e-03 | 10 | 129 | 2 | IPR017977 | |
| Domain | ZP_2 | 4.08e-03 | 14 | 129 | 2 | PS51034 | |
| Domain | ZP_1 | 4.08e-03 | 14 | 129 | 2 | PS00682 | |
| Domain | NPIP | 4.08e-03 | 14 | 129 | 2 | IPR009443 | |
| Domain | ZP | 4.69e-03 | 15 | 129 | 2 | SM00241 | |
| Domain | Post-SET_dom | 5.33e-03 | 16 | 129 | 2 | IPR003616 | |
| Domain | PostSET | 5.33e-03 | 16 | 129 | 2 | SM00508 | |
| Domain | POST_SET | 5.33e-03 | 16 | 129 | 2 | PS50868 | |
| Domain | ZP_dom | 6.02e-03 | 17 | 129 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 6.02e-03 | 17 | 129 | 2 | PF00100 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B UNC45B TBC1D3I TBC1D3G TBC1D3K | 3.30e-10 | 99 | 84 | 10 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.54e-27 | 11 | 132 | 11 | 16863688 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STAM2 LIMA1 MYCBP2 PPFIA1 CCDC18 RIPK2 PRAG1 NSD3 OPTN MTOR N4BP2 RPTOR PLEKHA3 ANKRD17 TANC1 GEN1 DOP1A VCPIP1 | 5.01e-09 | 861 | 132 | 18 | 36931259 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.41e-08 | 74 | 132 | 7 | 16625196 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 2.13e-07 | 4 | 132 | 3 | 12359748 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 8406013 | ||
| Pubmed | STAM2 RNF169 RPGRIP1L MYCBP2 CIP2A PPFIA1 CCDC18 ZYG11B NSD3 CASK EFR3A PHKA1 PTPRE VPS33B KCTD3 TANC1 KNL1 | 5.16e-07 | 1049 | 132 | 17 | 27880917 | |
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 12604796 | ||
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 8471161 | ||
| Pubmed | IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes. | 5.31e-07 | 5 | 132 | 3 | 18990450 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | STAM2 RPGRIP1L CIP2A SETD2 N4BP2 CEP44 RPTOR ZNF451 TANC1 FAM135A KNL1 VCPIP1 | 2.70e-06 | 588 | 132 | 12 | 38580884 |
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 29399633 | ||
| Pubmed | 4.41e-06 | 9 | 132 | 3 | 20439742 | ||
| Pubmed | RNF169 BIN1 RPGRIP1L MYCBP2 CIP2A PPFIA1 SETD2 ATAD1 N4BP2 ZNF451 TANC1 KNL1 VCPIP1 | 4.71e-06 | 733 | 132 | 13 | 34672954 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | RIPK2 APBB2 TEX11 ZBTB24 OPTN ABHD5 VPS33B CARD9 CEP44 CBY2 ZFP64 UMPS SYCE1 | 5.37e-06 | 742 | 132 | 13 | 26871637 |
| Pubmed | Interleukin-2 critically regulates bone marrow erythropoiesis and prevents anemia development. | 6.29e-06 | 10 | 132 | 3 | 26404745 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30202948 | ||
| Pubmed | VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer. | 1.43e-05 | 2 | 132 | 2 | 33788346 | |
| Pubmed | A role for cell-autocrine interleukin-2 in regulatory T-cell homeostasis. | 1.43e-05 | 2 | 132 | 2 | 32187647 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26626498 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18270303 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12438318 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27649073 | ||
| Pubmed | mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors. | 1.43e-05 | 2 | 132 | 2 | 29786082 | |
| Pubmed | Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning. | 1.43e-05 | 2 | 132 | 2 | 27018708 | |
| Pubmed | Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling. | 1.43e-05 | 2 | 132 | 2 | 27018889 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 16847060 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25486193 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17301289 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17698027 | ||
| Pubmed | Conditional Knockout of Raptor/mTORC1 Results in Dentin Malformation. | 1.43e-05 | 2 | 132 | 2 | 30984011 | |
| Pubmed | Hepatic peroxisomal β-oxidation suppresses lipophagy via RPTOR acetylation and MTOR activation. | 1.43e-05 | 2 | 132 | 2 | 32687428 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 24548303 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23209314 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 10419884 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20439490 | ||
| Pubmed | 2.57e-05 | 225 | 132 | 7 | 25277244 | ||
| Pubmed | 3.31e-05 | 418 | 132 | 9 | 34709266 | ||
| Pubmed | Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model. | 4.28e-05 | 3 | 132 | 2 | 35763354 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23440873 | ||
| Pubmed | mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. | 4.28e-05 | 3 | 132 | 2 | 25385646 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 28813526 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 28283069 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 25590474 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 17656678 | ||
| Pubmed | Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. | 4.28e-05 | 3 | 132 | 2 | 20008564 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 22356909 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 33728612 | ||
| Pubmed | Diversity of human copy number variation and multicopy genes. | 4.28e-05 | 3 | 132 | 2 | 21030649 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 17537734 | ||
| Pubmed | mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation. | 4.28e-05 | 3 | 132 | 2 | 26522726 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 24315998 | ||
| Pubmed | Leucine regulates autophagy via acetylation of the mTORC1 component raptor. | 4.28e-05 | 3 | 132 | 2 | 32561715 | |
| Pubmed | Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. | 4.28e-05 | 3 | 132 | 2 | 19864431 | |
| Pubmed | Protein kinase C theta plays a fundamental role in different types of chronic colitis. | 4.28e-05 | 3 | 132 | 2 | 18155708 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 24567410 | ||
| Pubmed | mTOR has distinct functions in generating versus sustaining humoral immunity. | 4.28e-05 | 3 | 132 | 2 | 27760048 | |
| Pubmed | Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine. | 4.28e-05 | 3 | 132 | 2 | 26314207 | |
| Pubmed | Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population. | 4.28e-05 | 3 | 132 | 2 | 23423739 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 30765845 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23966835 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 26678875 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 31393896 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 19145465 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 20233713 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 21471201 | ||
| Pubmed | The Potential Role of BRCA1-Associated ATM Activator-1 (BRAT1) in Regulation of mTOR. | 4.28e-05 | 3 | 132 | 2 | 25657994 | |
| Pubmed | Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course. | 4.28e-05 | 3 | 132 | 2 | 23898069 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 12912989 | ||
| Pubmed | Localization of Rheb to the endomembrane is critical for its signaling function. | 4.28e-05 | 3 | 132 | 2 | 16631613 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 22143799 | ||
| Pubmed | Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. | 4.28e-05 | 3 | 132 | 2 | 19724909 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23359502 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 27521345 | ||
| Pubmed | mTORC1 Signaling is a Critical Regulator of Postnatal Tendon Development. | 4.28e-05 | 3 | 132 | 2 | 29215029 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 21169543 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 18614546 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 27342766 | ||
| Pubmed | Parkin ubiquitinates mTOR to regulate mTORC1 activity under mitochondrial stress. | 4.28e-05 | 3 | 132 | 2 | 25007995 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 22504639 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23541542 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 12408816 | ||
| Pubmed | GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling. | 4.28e-05 | 3 | 132 | 2 | 26348909 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 21425313 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 25849663 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 26683665 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 23427250 | ||
| Pubmed | Reconstitution of leucine-mediated autophagy via the mTORC1-Barkor pathway in vitro. | 4.28e-05 | 3 | 132 | 2 | 22258093 | |
| Pubmed | TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. | 4.28e-05 | 3 | 132 | 2 | 12747827 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 35281599 | ||
| Pubmed | Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. | 4.28e-05 | 3 | 132 | 2 | 23212520 | |
| Pubmed | mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. | 4.28e-05 | 3 | 132 | 2 | 24958889 | |
| Pubmed | Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. | 4.28e-05 | 3 | 132 | 2 | 24462113 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 37967531 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 17041623 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 25906254 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 33627378 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 28686577 | ||
| Pubmed | VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma. | 4.28e-05 | 3 | 132 | 2 | 34290272 | |
| Pubmed | 4.53e-05 | 102 | 132 | 5 | 11214970 | ||
| Pubmed | 5.14e-05 | 251 | 132 | 7 | 29778605 | ||
| Interaction | YWHAH interactions | OARD1 STAM2 LIMA1 RPGRIP1L MYCBP2 SPEG PPFIA1 CCDC18 RIPK2 CEP128 PRAG1 NSD3 OPTN MTOR RPTOR PLEKHA3 ANKRD17 TANC1 GEN1 DOP1A VCPIP1 | 6.70e-06 | 1102 | 129 | 21 | int:YWHAH |
| Interaction | TRIM41 interactions | ZNF138 RPGRIP1L CEP128 ZBTB24 TBC1D26 CEP44 ZFP64 ANKRD17 SYCE1 | 1.37e-05 | 223 | 129 | 9 | int:TRIM41 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B UNC45B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.18e-14 | 149 | 132 | 12 | chr17q12 |
| Cytoband | 17q12 | 4.53e-07 | 99 | 132 | 6 | 17q12 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 8.32e-05 | 4 | 68 | 2 | 1332 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 5.12e-06 | 195 | 127 | 8 | M13736 | |
| Coexpression | GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 5.52e-06 | 197 | 127 | 8 | M9250 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 4.25e-09 | 90 | 130 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D PRAG1 TBC1D3C TBC1D3B CDRT4 TBC1D3G TBC1D3K TBC1D3F | 4.53e-06 | 320 | 130 | 11 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 6.70e-06 | 213 | 130 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 6.70e-06 | 213 | 130 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CIP2A CCDC18 DGKD TEX11 PHKA1 TRMT10A VPS33B BRDT MTOR ZNF451 KCTD3 MAEL CPLANE1 DNAH8 FAM135A SYCE1 DOP1A | 1.09e-05 | 820 | 130 | 17 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.86e-05 | 242 | 130 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | MYCBP2 TRIM35 SPEG ZYG11B NSD3 CASK EFR3A TRPM5 CPLANE1 FAM135A | 2.29e-05 | 312 | 130 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 2.37e-05 | 56 | 130 | 5 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#1_top-relative-expression-ranked_200 | 2.83e-05 | 29 | 130 | 4 | gudmap_developingGonad_e14.5_ testes_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.40e-05 | 201 | 130 | 8 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.97e-05 | 281 | 130 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.97e-05 | 281 | 130 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 6.09e-05 | 68 | 130 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.65e-05 | 115 | 130 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_200 | 7.77e-05 | 14 | 130 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_100 | 2.37e-04 | 20 | 130 | 3 | gudmap_developingGonad_e16.5_testes_100_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 2.52e-04 | 143 | 130 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | CIP2A CCDC18 TRMT10A VPS33B MTOR ZNF451 KCTD3 CPLANE1 FAM135A | 3.89e-04 | 361 | 130 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | GTPBP4 CIP2A CCDC18 DHX33 TEX11 TRMT10A OPTN BRDT MTOR ZNF451 MAEL CPLANE1 FAM135A SYCE1 | 4.50e-04 | 810 | 130 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.51e-04 | 104 | 130 | 5 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_200 | 4.67e-04 | 25 | 130 | 3 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_200 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.33e-06 | 148 | 132 | 6 | 10dcbdb47cac908648d9d652c8095b536db19b8a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 175 | 132 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-05 | 178 | 132 | 6 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 182 | 132 | 6 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 186 | 132 | 6 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 186 | 132 | 6 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 132 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 188 | 132 | 6 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.41e-05 | 193 | 132 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| Disease | macrophage inflammatory protein 1b measurement | 1.46e-06 | 136 | 120 | 7 | EFO_0008219 | |
| Disease | Primary microcephaly | 1.80e-06 | 22 | 120 | 4 | C0431350 | |
| Disease | CCL4 measurement | 7.11e-05 | 20 | 120 | 3 | EFO_0004751 | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 9.79e-05 | 4 | 120 | 2 | C0410204 | |
| Disease | Malignant neoplasm of breast | AKAP6 THOC5 MRPS7 SETD2 TRMT10A MTOR UNC45B N4BP2 ZFP64 UMPS CLUL1 KAT6B GEN1 DOP1A | 1.22e-04 | 1074 | 120 | 14 | C0006142 |
| Disease | tongue squamous cell carcinoma (biomarker_via_orthology) | 2.43e-04 | 6 | 120 | 2 | DOID:0050865 (biomarker_via_orthology) | |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.71e-04 | 31 | 120 | 3 | C1335167 | |
| Disease | Cerebellar Diseases | 3.40e-04 | 7 | 120 | 2 | C0007760 | |
| Disease | thiamine measurement | 7.23e-04 | 10 | 120 | 2 | EFO_0010540 | |
| Disease | Gastric Adenocarcinoma | 8.22e-04 | 45 | 120 | 3 | C0278701 | |
| Disease | diet measurement, adiponectin measurement | 8.81e-04 | 11 | 120 | 2 | EFO_0004502, EFO_0008111 | |
| Disease | kidney cancer | 8.81e-04 | 11 | 120 | 2 | MONDO_0002367 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.12e-03 | 50 | 120 | 3 | EFO_0022334 | |
| Disease | seasonal gut microbiome measurement | 1.15e-03 | 112 | 120 | 4 | EFO_0007753 | |
| Disease | refractive error, age at onset, Myopia | 1.18e-03 | 193 | 120 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.18e-03 | 51 | 120 | 3 | EFO_0022331 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 1.45e-03 | 14 | 120 | 2 | DOID:627 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.45e-03 | 14 | 120 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | leukemia | 1.48e-03 | 55 | 120 | 3 | C0023418 | |
| Disease | triacylglycerol 52:3 measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0010415 | |
| Disease | Autosomal recessive primary microcephaly | 1.66e-03 | 15 | 120 | 2 | cv:C3711387 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.66e-03 | 15 | 120 | 2 | C3645536 | |
| Disease | creatine kinase measurement | 1.81e-03 | 59 | 120 | 3 | EFO_0004534 | |
| Disease | Malignant Neoplasms | 1.88e-03 | 128 | 120 | 4 | C0006826 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 1.90e-03 | 16 | 120 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Hypercholesterolemia, Familial | 2.40e-03 | 18 | 120 | 2 | C0020445 | |
| Disease | common carotid intimal medial thickness | 2.60e-03 | 67 | 120 | 3 | EFO_0004860 | |
| Disease | Omenn Syndrome | 2.68e-03 | 19 | 120 | 2 | C2700553 | |
| Disease | Familial aplasia of the vermis | 2.97e-03 | 20 | 120 | 2 | cv:C0431399 | |
| Disease | Severe Combined Immunodeficiency | 2.97e-03 | 20 | 120 | 2 | C0085110 | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.97e-03 | 20 | 120 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 3.27e-03 | 21 | 120 | 2 | EFO_0022262 | |
| Disease | age at onset, Myopia | 3.34e-03 | 150 | 120 | 4 | EFO_0004847, HP_0000545 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.59e-03 | 22 | 120 | 2 | C3711387 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLQFLTCKEKMDHKT | 481 | Q6N043 | |
| RCMERKDKEKAHLAS | 386 | Q6ZU80 | |
| LHEICSKIMAERKNA | 541 | Q92870 | |
| EAMCKHRKLNAVTKE | 431 | Q75V66 | |
| CSEILKEMLAKKHFS | 276 | Q58F21 | |
| LLRLMFKSKCKSLES | 961 | Q8N7X0 | |
| CDRLLAHRVETKMKG | 336 | Q9BZE4 | |
| DILNCVMKKHKELSS | 111 | Q9C0F1 | |
| LSKRLKHKDDSVMKA | 101 | O95567 | |
| SDMLSKCKVQKVILH | 1516 | Q5JWR5 | |
| DVKTKITREEKHFMC | 66 | Q86XS5 | |
| YIATITDKEMLKKCH | 1421 | O75179 | |
| SLMKAEDDCKVERKH | 216 | Q9H257 | |
| FRDKCMLPKSLEKHE | 641 | Q14156 | |
| PKTHRKMARKECDLN | 226 | Q5T6C5 | |
| LDLVKKVLASHKCQM | 291 | Q9UKD1 | |
| DVMKKIANCSKIHLS | 261 | P15918 | |
| TEVLLKVMDAKHKNC | 551 | P52333 | |
| MAFKLKSKSCHDLSV | 281 | P55040 | |
| EKLILSHMEKLKTCS | 961 | Q8WYB5 | |
| KRLIEKSKTRELECM | 41 | Q8N9R6 | |
| LQKSLEAMKSHCLKN | 96 | Q9Y530 | |
| TEDLKREASICHMLK | 56 | O14936 | |
| VMLTNLKERKEEKCH | 231 | P23469 | |
| RLCMMSSHLKKTEKA | 171 | O75121 | |
| CLKHMAKASEIRQDL | 226 | Q96JY0 | |
| MNEHLSSLIKKKRKC | 96 | Q8NEM0 | |
| LKDHSTESKKMENCL | 151 | Q9UHB6 | |
| RLKCCSLEKQLHSMK | 321 | Q68CZ1 | |
| AMKLNECVDHTPKLK | 186 | P78417 | |
| KGCLRALAMKFKTTH | 751 | Q9NS40 | |
| TCDLMSLVTKAKELH | 696 | P46020 | |
| ESLKEELMCLKKNHE | 221 | Q14532 | |
| RCLPEDIKKMTKDHL | 691 | Q9NYF5 | |
| KEKSVKHMDLCLTVV | 486 | Q10471 | |
| LKDMSKIILNAKCHA | 191 | Q9UL16 | |
| HSARIEMCKTALKDK | 1431 | Q9P2D6 | |
| ECESKLEAKKLAHAM | 201 | Q7Z2X4 | |
| IVKKIMHRAQTLLKC | 406 | Q9HCR9 | |
| ALAKKLKLECRTISM | 3926 | Q96JB1 | |
| CLKELMELKTKAREL | 86 | Q9UN81 | |
| ECLVDARMLDHLTKK | 986 | Q13136 | |
| KMRHCSDKELKAFGI | 1981 | Q8NG31 | |
| ICKMKVTTKVNRHDK | 121 | F8WFD2 | |
| CKMKVTTKVNRHDKI | 141 | E9PIF3 | |
| DASEEKKARHMRKCA | 226 | Q96PC2 | |
| VAMKLLHQVSKLCGK | 931 | Q5TIA1 | |
| AAHCMDESKKLLVRL | 251 | P04070 | |
| KLHHKRLAKECMLQE | 156 | Q8NA61 | |
| LMGHLSCDTKEERKI | 1106 | P04114 | |
| MPKKATELKHLQCLE | 66 | P60568 | |
| ELTSIHKPTDKRKMC | 1501 | Q9H799 | |
| EKLRKMEEKCESAAH | 836 | Q5T9S5 | |
| MEKESCSHLKSDLVR | 1096 | Q68DX3 | |
| DVSSRMALREKLKCK | 461 | Q9NY28 | |
| TKRCLEMKKDLLGSH | 596 | Q9NY28 | |
| IEAMSKTCRDIAKHL | 301 | Q9H6R0 | |
| KSAICHKTLKNIERM | 331 | Q9H222 | |
| LLHSCTTEKDSRKMK | 66 | Q8WV07 | |
| KAMVHTSCKESLLTK | 271 | Q16760 | |
| TRKILMKKSVCLDRH | 786 | Q17RS7 | |
| CLTMKEKKSSISQIH | 2296 | Q8NDH2 | |
| SVKAMHEASKKLNEC | 71 | O00499 | |
| KIMLSEKHLVSVCAD | 426 | Q9Y597 | |
| AHTKLSEAELMKKRL | 316 | Q96CV9 | |
| TMNHVLSCVKKEKER | 416 | P42345 | |
| DIKMHAVVKKLCLID | 861 | Q86VV8 | |
| CLDLLTEMSKYKHKS | 2101 | Q86VV8 | |
| CRDKKHQRTLMPEKL | 191 | Q9Y2R9 | |
| CRDVALVVTKMDKLH | 346 | Q68CJ6 | |
| AKCRNMEHALREKAK | 146 | Q9UPQ4 | |
| EKHKLAKLCGMLTIT | 486 | Q7RTY7 | |
| AAAGHMKLVCLLTKK | 976 | Q9C0D5 | |
| RKILSEGVDHCMVKL | 1506 | O75592 | |
| SDSRECKLMKKLLEA | 236 | P54920 | |
| DAKLDKTCISRAMKI | 556 | Q8NCN4 | |
| MKEKGKRSSRIIHCI | 131 | Q86UD7 | |
| ALAAAQRCHKKVMKE | 531 | Q9H6T0 | |
| EDTVLKHLRASMKKL | 336 | B9A6J9 | |
| KLETHASMRKKLCDI | 106 | O60518 | |
| SHVSKECKDLITRML | 236 | Q9NRH2 | |
| MKKRHCEKIEGSKSL | 31 | Q8N122 | |
| SISHLKEAEEKMLKC | 31 | Q8WTS1 | |
| MSIRHLKKTELLSKV | 1006 | Q13023 | |
| LHRAIEKMKKSKDAA | 336 | Q8NBU5 | |
| TLKMHIAKILTTVKC | 431 | Q8TCG1 | |
| KEKEHTNLMSTLKKC | 66 | Q15846 | |
| EDTVLKHLRASMKKL | 336 | A6NDS4 | |
| EDTVLKHLRASMKKL | 336 | P0C7X1 | |
| LTAAHKKLCLKMTQV | 831 | Q8IWX7 | |
| CKKELTRKDTIMAHV | 536 | Q9Y4E5 | |
| ACKDRLKSLTMHHLK | 206 | Q9C0D3 | |
| LSLMREKLCESKESH | 66 | P17024 | |
| DKSLCMLSRLTQHKK | 116 | P52744 | |
| ACKILKEMSHLETEA | 551 | Q9NZQ8 | |
| KMHFDGRKCKLLLTS | 1016 | Q15772 | |
| EDTVLKHLRASMKKL | 336 | A6NER0 | |
| KTEHKALACERAALM | 141 | Q8N271 | |
| FSHKIHLETMCEVKK | 251 | Q8WU10 | |
| KHITSLKKAVDMTCH | 126 | Q13888 | |
| KHTMLQECKERISAL | 126 | Q8N0S2 | |
| HRETKKMFCEVDKSL | 96 | Q9BSJ1 | |
| SVSSAIHLCDKKKME | 316 | O43353 | |
| IHLCDKKKMELSLNI | 321 | O43353 | |
| HFAKEESALMCKKLT | 151 | O94964 | |
| TLDVMKELITLAKCH | 291 | P11172 | |
| SEDKKKEMDRLLTCL | 596 | Q8IYF3 | |
| AHPKVCEKLKSLMVE | 101 | O75886 | |
| EDTVLKHLRASMKKL | 336 | A0A087X179 | |
| AAKKAVMDNRLHKCL | 456 | Q96JH7 | |
| RHLLKMNKSSSDLEK | 721 | Q86YV5 | |
| MCETKILSLKKRHFS | 111 | Q3KNS6 | |
| ACSMEKDIHKASKGR | 801 | Q9BZ95 | |
| RCKEKDLDDTCMLHK | 726 | Q9BYW2 | |
| LKMKCSRHKVCIAQD | 91 | Q9BQ16 | |
| KGSIKMAVCEIKVHS | 41 | Q9HB20 | |
| CHRKFMDVSQLKKHL | 411 | O43167 | |
| MKEKGKRSSRIIHCI | 131 | Q2M2D7 | |
| DCSFDHLMVLKDIKK | 106 | Q8TBZ6 | |
| EDTVLKHLRASMKKL | 336 | A0A087WVF3 | |
| KIKNVHMRGLDKETC | 476 | Q14139 | |
| LKRHPLSVMLDLKCK | 341 | Q13769 | |
| EDTVLKHLRASMKKL | 336 | Q6DHY5 | |
| EDTVLKHLRASMKKL | 336 | Q8IZP1 | |
| GKCFSRKDKLKTHMR | 181 | Q9NTW7 | |
| EDTVLKHLRASMKKL | 336 | A0A087X1G2 | |
| LSLHIGACESIMKKK | 341 | Q9H267 | |
| EHKVVTERKLLKCPM | 116 | Q12836 | |
| EDTVLKHLRASMKKL | 336 | A0A087WXS9 | |
| EDTVLKHLRASMKKL | 336 | Q6IPX1 | |
| ELTLCTKMEKHPQKL | 706 | Q03167 | |
| SMCFHDRLKTLTKIK | 696 | Q96MR9 | |
| RLRKDCKSANEGKMH | 121 | A6NN14 | |
| RKCFDLKILKSLSME | 151 | O43264 | |
| KLREVMHKKTCDVLK | 556 | Q8TEU8 | |
| MHKKTCDVLKEFLGL | 561 | Q8TEU8 | |
| EIHKLKDMTCLKPSI | 266 | Q9NR99 | |
| KHNLKRETLMFEKDC | 1506 | Q86UW6 |